## Intravesical administration of Bacillus Calmette-Guerin (BCG) causes a localized cell-mediated immune response. The intensity of this inflammatory response may be gauged by measuring the levels of both interleukin-2 (IL-2) and an inhibitor of interleukin-2 (IL-2-IN) activity in the urine during
Increased urinary albumin indicating urothelial leakage following intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer
✍ Scribed by de Boer, E. C. ;De Reijke, T. M. ;Schamhart, D. H. J. ;Vos, P. C. N. ;Kurth, K. H.
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 528 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We evaluated the clinical significance of Th1(IL‐2)/Th2(IL‐10) urinary profiles during a weekly induction course lasting 6 weeks, followed by a weekly maintenance therapy schedule for 3 weeks. Urinary IL‐2 and /IL‐10 were measured by ELISA in 39 patients receiving BCG for superficial bl
## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc